Optimal HAART adherence over time and time interval between successive visits: their association and determinants
- PMID: 21767110
- PMCID: PMC3630300
- DOI: 10.1080/09540121.2011.565028
Optimal HAART adherence over time and time interval between successive visits: their association and determinants
Abstract
We aimed to investigate the determinants of optimal highly active antiretroviral therapy (HAART) adherence and time interval between successive clinic visits, and the association between these two processes. This was done by reviewing routinely collected patient information in the Centre for the AIDS Programme of Research in South Africa (CAPRISA). Records of 688 patients enrolled in the CAPRISA AIDS treatment (CAT) programme between 2004 and 2006 were analysed. Patients were considered adherent if they had taken at least 95% of their prescribed drugs. The adherence has been measured using the pill counts data. A multivariate generalised mixed random effects approach was used to jointly analyse optimal HAART adherence and time interval between successive visits. The results showed that on the overall, the association between optimal HAART adherence and time interval between successive visits was negative. The results further showed that the interaction between time and treatment site had a significant joint effect on optimal HAART adherence and time interval between successive visits. The interaction revealed that as the number of follow-up visits increased, the interval between successive visits also increased while at the same time high levels of optimal adherence were maintained in the rural treatment site. Moreover, after accounting for the time interval between successive visits, the results showed that optimal HAART adherence was significantly associated with having a cell phone, living with a partner as well as interactions that include time and gender, time and treatment site, age and gender and age and education. The findings provide evidence of a negative association between optimal HAART adherence and the time interval between successive clinic visits on the overall, which therefore indicates that longer time interval between successive clinic visits is undesirable if optimal HAART adherence is to be maintained. This notwithstanding, rural patients were able to maintain HAART adherence for longer time interval between successive clinic visits. Furthermore, the findings indicated that optimal HAART adherence was low for some sub-populations, such as the urban and male populations, thus vigorous ongoing adherence counseling is required.
Figures
Similar articles
-
Determinants of optimal adherence over time to antiretroviral therapy amongst HIV positive adults in South Africa: a longitudinal study.AIDS Behav. 2011 Oct;15(7):1465-74. doi: 10.1007/s10461-010-9688-x. AIDS Behav. 2011. PMID: 20352319 Free PMC article.
-
One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients.J Intern Med. 2007 Mar;261(3):268-75. doi: 10.1111/j.1365-2796.2006.01762.x. J Intern Med. 2007. PMID: 17305649
-
Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study.BMC Infect Dis. 2018 Feb 20;18(1):83. doi: 10.1186/s12879-018-2977-0. BMC Infect Dis. 2018. PMID: 29458343 Free PMC article.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Exploring optimal HAART adherence rates in Ethiopian adults: a systematic review and meta-analysis.Front Public Health. 2024 Oct 14;12:1390901. doi: 10.3389/fpubh.2024.1390901. eCollection 2024. Front Public Health. 2024. PMID: 39469205 Free PMC article.
Cited by
-
Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa.Trop Med Int Health. 2020 Oct;25(10):1246-1260. doi: 10.1111/tmi.13473. Epub 2020 Aug 26. Trop Med Int Health. 2020. PMID: 32745296 Free PMC article.
-
The Future of Telehealth in Human Immunodeficiency Virus Care: A Qualitative Study of Patient and Provider Perspectives in South Carolina.AIDS Patient Care STDS. 2023 Oct;37(10):459-468. doi: 10.1089/apc.2023.0176. AIDS Patient Care STDS. 2023. PMID: 37862076 Free PMC article.
-
Evidence of reduced treatment adherence among HIV infected paediatric and adolescent populations in Nairobi at the onset of the UNAIDS Universal Test and Treat Program.BMC Res Notes. 2018 Feb 17;11(1):134. doi: 10.1186/s13104-018-3205-0. BMC Res Notes. 2018. PMID: 29452597 Free PMC article.
-
Socio-Demographic, Economic and Clinical Predictors for HAART Adherence Competence in HIV-Positive Adults at Felege Hiwot Teaching and Specialized Hospital, North West Ethiopia.HIV AIDS (Auckl). 2021 Jul 9;13:749-758. doi: 10.2147/HIV.S320170. eCollection 2021. HIV AIDS (Auckl). 2021. PMID: 34267557 Free PMC article.
-
Variation in subsequent viral load testing and outcomes by visit type patterns in the first year of the COVID-19 pandemic at a large academic medical center in North Carolina.Mhealth. 2025 Mar 21;11:18. doi: 10.21037/mhealth-24-69. eCollection 2025. Mhealth. 2025. PMID: 40248755 Free PMC article.
References
-
- Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A. Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome. 2001;26:435–442. - PubMed
-
- Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, Moss A. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS. 2003;17:1925–1932. - PubMed
-
- Birbeck GL, Chomba E, Kvalsund M, Bradbury R, Mang’ombe C, Malama K, Orgnek N. Antiretroviral adherence in rural Zambia: the first year of treatment availability. American Journal of Tropical Medicine and Hygiene. 2009;80:669–674. - PubMed
-
- Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR. Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. International Journal of STD and AIDS. 2005;16:38–41. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous